{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:40:52Z","timestamp":1789839652184,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.modpat.2026.100991","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:52:24Z","timestamp":1773967944000},"page":"100991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiple Myeloma and Mimicry: Gastrointestinal Tract Histologic Findings in Patients Following Chimeric Antigen Receptor T-cell Therapy and Anti-CD38 Monoclonal Antibodies"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8827-6794","authenticated-orcid":false,"given":"Domenika","family":"Ortiz Requena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemencio R.","family":"Ronquillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Garcia-Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda K.","family":"Yantiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.modpat.2026.100991_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.modpat.2026.100991_bib2","first-page":"2377","article-title":"Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes","volume":"32","author":"Shirasu","year":"2012","journal-title":"Anticancer Res"},{"issue":"25","key":"10.1016\/j.modpat.2026.100991_bib3","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1200\/JCO.19.03237","article-title":"Long-term outcomes from a randomized dose optimization study of chimeric antigen receptor modified T cells in relapsed chronic lymphocytic leukemia","volume":"38","author":"Frey","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2026.100991_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.modpat.2026.100991_bib5","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.modpat.2026.100991_bib6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","article-title":"HER2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial","volume":"3","author":"Ahmed","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.modpat.2026.100991_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.omto.2020.04.008","article-title":"LunX-CAR T cells as a targeted therapy for non-small cell lung cancer","volume":"17","author":"Hu","year":"2020","journal-title":"Mol Ther Oncolytics"},{"issue":"4","key":"10.1016\/j.modpat.2026.100991_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jnci\/djy134","article-title":"Claudin18.2-specific chimeric antigen receptor engineered T cells for the treatment of gastric cancer","volume":"111","author":"Jiang","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.modpat.2026.100991_bib9","doi-asserted-by":"crossref","first-page":"438.e1","DOI":"10.1016\/j.jtct.2023.03.006","article-title":"Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome","volume":"29","author":"Hines","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.modpat.2026.100991_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41408-022-00629-1","article-title":"Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies","volume":"12","author":"Cohen","year":"2022","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.modpat.2026.100991_bib11","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/ibd\/izaa320","article-title":"Colitis after CAR T-cell therapy for refractory large B-cell lymphoma responds to anti-integrin therapy","volume":"27","author":"Hashim","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.modpat.2026.100991_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105791","article-title":"Chimeric antigen receptor (CAR) T-cell therapy-related gastrointestinal toxicity: histologic features and morphologic mimics","volume":"158","author":"Karimi","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.100991_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1149450","article-title":"Case report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma","volume":"13","author":"Zundler","year":"2023","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2026.100991_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/COC.0000000000000596","article-title":"Gastrointestinal adverse events observed after chimeric antigen receptor T-cell therapy","volume":"42","author":"Abu-Sbeih","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.100991_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.modpat.2026.100991_bib16","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.100991_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41408-024-01167-8","article-title":"Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma","volume":"14","author":"Fortuna","year":"2024","journal-title":"Blood Cancer J"},{"issue":"12","key":"10.1016\/j.modpat.2026.100991_bib18","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.100991_bib19","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","article-title":"Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia","volume":"20","author":"Washington","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.100991_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bmt.2009.157","article-title":"A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT","volume":"45","author":"Goddard","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.modpat.2026.100991_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14740\/gr925w","article-title":"Autologous graft-versus-host disease of the gastrointestinal tract in patients with multiple myeloma and hematopoietic stem cell transplantation","volume":"11","author":"Hammami","year":"2018","journal-title":"Gastroenterology Res"},{"issue":"12","key":"10.1016\/j.modpat.2026.100991_bib22","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000522","article-title":"Idelalisib-associated colitis: histologic findings in 14 patients","volume":"39","author":"Weidner","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.100991_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/his.13118","article-title":"PD-1 inhibitor gastroenterocolitis: case series and appraisal of \u2018immunomodulatory gastroenterocolitis\u2019","volume":"70","author":"Gonzalez","year":"2017","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.modpat.2026.100991_bib24","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/PAS.0000000000000525","article-title":"Idelalisib-associated enterocolitis: clinicopathologic features and distinction from other enterocolitides","volume":"39","author":"Louie","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.100991_bib25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1365-2559.2012.04305.x","article-title":"Microscopic features associated with mycophenolate mofetil in gastric and colonic biopsies","volume":"61","author":"Coyne","year":"2012","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.modpat.2026.100991_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/modpathol.2009.44","article-title":"Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil","volume":"22","author":"Selbst","year":"2009","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2026.100991_bib27","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/PAS.0000000000000921","article-title":"Differentiating posttransplant inflammatory bowel disease and other colitides in renal transplant patients","volume":"41","author":"Pittman","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.100991_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/PAS.0b013e3181a755bd","article-title":"Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract","volume":"33","author":"Nguyen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.100991_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/PAS.0000000000002197","article-title":"Histologic manifestations of gastrointestinal adenovirus infection after stem cell transplant","volume":"48","author":"Hissong","year":"2024","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:04:40Z","timestamp":1779282280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0893395226000347"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.100991","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Myeloma and Mimicry: Gastrointestinal Tract Histologic Findings in Patients Following Chimeric Antigen Receptor T-cell Therapy and Anti-CD38 Monoclonal Antibodies","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.100991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100991"}}